[DIV28SUPER] NYTimes: ‘I Don’t Believe in God, but I Believe in Lithium’

#div28 #apa2015

http://www.nytimes.com/2015/06/28/magazine/i-dont-believe-in-god-but-i-believe-in-lithium.html?smprod=nytcore-iphone&smid=nytcore-iphone-share

My 20-year struggle with bipolar disorder.


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 #apa2015 subscribers corner: http://lists.apa.org

Planning on a great convention in toronto!

division 28 will be there! #div28 #apa2015

[DIV28M] Postdoctoral Associate at Yale University School of Medicine

 

Dear Division 28 members,

 

Please see the attached notice advertising for a Postdoctoral Associate.

 

Best regards,

 

Brent A. Moore, Ph.D.

 

 

 

Research Scientist    

Department of Psychiatry

Yale University School of Medicine

495 Congress Ave.  – MRU Second Floor

New Haven, CT 06519

brent.moore@yale.edu

(203) 285-2700    Fax: (203) 781-4681

 

Research Psychologist

Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center

VA Connecticut Healthcare System

brent.moore@va.gov

Affiliate- Center for Interdisciplinary Research on AIDS

 

http://medicine.yale.edu/psychiatry/research/programs/divisions_people/brent_moore.profile

 

 

 

 

 

POSTDOCTORAL ASSOCIATE - YALE UNIVERSITY SCHOOL OF MEDICINE: Department of Psychiatry at Yale University School of Medicine, Division of Addictions in New Haven, CT seeks a motivated psychologist for a postdoctoral associate position on a NIDA R01 research project available by August, 2015. The project involves development and evaluation of automated, CBT-based, substance abuse treatments for individuals with opioid use disorder.  Additional opportunities for research in substance abuse, HIV/AIDS, chronic pain, and health services delivery are available.

 

Applicants should have a PhD with training in behavioral interventions and substance abuse and be a U.S. citizen or permanent resident. The successful candidate should have experience with clinical trials, data management and statistical experience, a strong interest in multidisciplinary research, and able to work effectively independently and in collaboration with a team. The position will involve close collaboration with the investigators and research team in all phases of research: conceptualization of new projects, grant writing, implementation of trials, data collection, management and analysis, writing up results, and presenting findings.

 

Yale University considers applicants for employment without regard to, and does not discriminate on the basis of, an individual’s sex, race, color, religion, age, disability, status as a veteran, or national or ethnic origin; nor does Yale discriminate on the basis of sexual orientation or gender identity or expression.

 

The Division of Addictions is a world-renowned research and training program with over 35 full-time research faculty and multiple research centers on addictions and affiliated disorders (http://psychiatry.yale.edu/research/divisions/addictions.aspx). The program is closely affiliated with the VA Connecticut Healthcare System in West Haven, CT which provides additional clinical, research and career opportunities. Send letter of interest, curriculum vitae, and three letters of reference to: Brent A. Moore, Ph.D., Department of Psychiatry, Yale University School of Medicine, Brent.Moore@yale.edu.

 

 

[DIV28SUPER] Division 28 program offerings at the 2015 Convention of the American Psychological Association in

Dear Colleagues,

 

The 2015 Convention of the American Psychological Association in Toronto, ON, is fast approaching!  As always this year’s Division 28 program includes several strong symposia, invited addresses, new fellows’ addresses, paper sessions, poster sessions, collaborative programing, and continuing education opportunities.  We have arranged for a diverse program that encompasses novel uses of technology, adolescent development, and more.  We are also co-hosting many events with allied divisions, societies, and institutions. A brief program brochure providing times and places is attached to this email, please take a minute to look over some highlights.  We hope to see you in Toronto, and be sure to bring your passport if you plan to attend and live outside of Canada.

 

Cheers,

 

 

Matthew T. Weaver, Ph.D.

2015 Program Chair

American Psychological Association

Divions 28: Psychopharmacology and Substance Abuse

Phone: 814.824.2733

Email: mweaver@mercyhurst.edu

P Please consider the environment before printing this correspondence.

 

************************

Statement of Confidentiality:

The contents of this e-mail message and any attachments are confidential and are intended solely for addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If are not the intended addressee or you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or phone and delete this message and its attachments, if any.

 

[DIV28M] new officers

Dear Division 28 Members-
Please join me in congratulating our two newly elected officers. David Festinger Ph.D. will be our president in 2017. Cecile Marczinski Ph.D. will be our member-at-large from 2016-2018. Welcome, David and Cecile!
-Bill.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[DIV28SUPER] Nora's Blog Seeking Input from the Community on NIDA=?Windows-1252?Q?=92s_?=Scientific Reorganization | National Institute on Drug Abuse (NIDA)

FYI, as promised...
http://www.drugabuse.gov/about-nida/noras-blog/2015/06/seeking-input-community-nidas-scientific-reorganization

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Correction on date: Webinar opportunity June 19 - Reorganization of NIDA translational neuroscience and neurobehavioral research

Sorry, corrected date in subject line – June 19.

-geoff

 

From: Mumford, Geoff
Sent: Tuesday, June 09, 2015 2:38 PM
To: CPDD@VENUS.VCU.EDU; div28super@lists.apa.org; 'apadiv50-forum@mailman.yale.edu'
Subject: Webinar opportunity June 15 - Reorganization of NIDA translational neuroscience and neurobehavioral research

 

FYI, NIDA will be hosting a webinar on June 19 at 3:00 ET to provide updates on its proposed reorganization of translational neuroscience and neurobehavioral research; click here for registration details. An on-line summary of the proposed reorganization will be provided by Dr. Volkow on her blog on June 12 and comments will be invited.

 

Background:

At its May 2015 meeting, the NIDA Advisory Council received a summary report from the Division of Clinical Neuroscience and Behavioral Research (DCNBR) Review Work Group (the full report is available here).

 

Best,

-geoff

 

Geoffrey K. Mumford, Ph.D. | Associate Executive Director for Government Relations Science Directorate American Psychological Association 750 First Street NE, Washington, DC 20002-4242 Tel: 202.336.6067 |  Fax: 202.336.6063 email: gmumford@apa.org | www.apa.org
P Most people consider the environment before printing their email.

 

 

 

 

 

[DIV28SUPER] Webinar opportunity June 15 - Reorganization of NIDA translational neuroscience and neurobehavioral research

FYI, NIDA will be hosting a webinar on June 19 at 3:00 ET to provide updates on its proposed reorganization of translational neuroscience and neurobehavioral research; click here for registration details. An on-line summary of the proposed reorganization will be provided by Dr. Volkow on her blog on June 12 and comments will be invited.

 

Background:

At its May 2015 meeting, the NIDA Advisory Council received a summary report from the Division of Clinical Neuroscience and Behavioral Research (DCNBR) Review Work Group (the full report is available here).

 

Best,

-geoff

 

Geoffrey K. Mumford, Ph.D. | Associate Executive Director for Government Relations Science Directorate American Psychological Association 750 First Street NE, Washington, DC 20002-4242 Tel: 202.336.6067 |  Fax: 202.336.6063 email: gmumford@apa.org | www.apa.org
P Most people consider the environment before printing their email.

 

 

 

 

 

[DIV28SUPER] NIDA Neuroscience Update June 3, 2015

---

Table of Contents

 

I.    Request for Information: NIH Precision Medicine Cohort - Strategies to Address Community Engagement and Health Disparities NOT-OD-15-107 http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-107.html

 

II.     Harnessing Genome Editing Technologies to Functioning Validate Genetic Variants in Substance Use Disorders (R21/R33) RFA-DA-16-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

 

III.    Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)  http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

 

IV.    Rat Genetics and Genomics for Psychiatric Disorders and Addiction Workshop  June 29, 2015, University of Chicago, Chicago, IL http://ratgenes.org/register/ 

 

V.     Short Course on the Genetics of Addiction August 24-30, 2015, Bar Harbor, ME   http://courses.jax.org/2015/addiction.html   Application deadline: July 24, 2015

 

 

 

 

I.              Request for Information: NIH Precision Medicine Cohort - Strategies to Address Community Engagement and Health Disparities NOT-OD-15-107 http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-107.html

 

Response Date: June 19, 2015

---

National Institutes of Health (NIH)

 

Purpose

This Request for Information (RFI) seeks feedback to help guide creating the National Institutes of Health (NIH)'s national research cohort of 1 million or more Americans as part of the President's proposed Precision Medicine Initiative (PMI), specifically as it relates to the development and implementation of effective community engagement strategies for the cohort, and to the advancement the cohort's ability to conduct transformative research to address health disparities. Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle. In order for the benefits of precision medicine and the PMI to be available to all people, including those who are medically underserved and/or historically underrepresented in biomedical research, or who, for reasons of systematic social disadvantage experience disparities in health, the NIH aims to assemble a cohort reflective of the rich diversity of the U.S. population.

Please see full notice for information requested http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-107.html and how to respond to RFI by June 19, 2015.

Please direct all inquiries to:
pmicommunityengagementrfi@mail.nih.gov

--------------------------------------------------------------------------------------------------------------------

II.             Harnessing Genome Editing Technologies to Functioning Validate Genetic Variants in Substance Use Disorders (R21/R33) RFA-DA-16-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

 

Funding Opportunity Purpose

The purpose of this initiative is to harness genome or epigenome editing technologies to functionally validate and characterize genetic or epigenetic variants involved in substance use disorders.  The purpose is also that the genetic resources generated will be made broadly available to the scientific community to probe more deeply into the neurobiological mechanisms involved in the function of a variant, gene, or pathway and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.

Please see full announcement for details. http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

Scientific/Research Contact(s):

 

John Satterlee, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: satterleej@nida.nih.gov

-----------------------

III.            Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)  http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

Next due dates: June 30, 2015; October 20, 2015

 

The goals of this initiative are to identify gene variants of traits associated with addiction and substance abuse in selectively bred, and outbred  non-human animal models using methodologies of Next Gen-Sequencing, mapping, and genotyping.

 

This FOA will replace PAR-14-010 "Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)".

See complete announcement  at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

--------------------

 

IV.            Rat Genetics and Genomics for Psychiatric Disorders and Addiction Workshop

 

Will be held on Monday, June 29, 2015,   University of Chicago.

Poster session: three winners of best posters will win $300.

Registration is free. For more information and to register please go to ratgenes.org/register

 Speakers:

Amelie Baud, Ph.D., EMBL - European Bioinformatics Institute

Mark S. Brodie, Ph.D., University of Illinois at Chicago

Aron Geurts, Ph.D., Medical College of Wisconsin

David Goldman, M.D., NIAAA

David Jentsch, Ph.D., Ph.D., UCLA

Thomas Jhou, Ph.D., Medical University of South Carolina

Paul J. Kenny, Ph.D., School of Medicine at Mount Sinai

Margaret McCarthy, Ph.D., University of Maryland School of Medicine

Abraham A. Palmer, Ph.D., University of Chicago

Daniel McGehee, Ph.D., University of Chicago

Celeste Napier, Ph.D., Rush University Medical Center

Subhash C. Pandey, Ph.D., University of Illinois at Chicago

Marina Wolf, Ph.D., Rosalind Franklin University of Medicine and Science

 

 

 

V.             Short Course on the Genetics of Addiction: 

Supported by National Institute on Drug Abuse Grant – DA032192, The Howard Hughes Medical Institute, LabDiet and TestDiet

Application deadline: July 24, 2015

Date: August 24-30, 2015

Location: The Jackson Laboratory in Bar Harbor, Maine

Website: http://courses.jax.org/2015/addiction.html  

 Scholarships are available!

This course emphasizes genetic applications and approaches to drug addiction research through methodological instruction based on literature, data sets and informatics resources drawn from studies of addiction related phenotypes. The course includes plenary sessions on major progress in addiction genetics, and discussion sessions in which students present their work for discussion on applications of genetic methods. Students will leave the course able to design and interpret genetic and genomic studies of addiction as they relate to their specific research question, and will be able to make use of current bioinformatics resources to identify research resources and make use of public data sources in their own research.

 For more information or to apply for this event, please go to http://courses.jax.org/2015/addiction.html   or contact Erin McDevitt; erin.mcdevitt@jax.org or 207-288-6659

 

Erin McDevitt

Senior Events & Meetings Planner

207.288.6659 t  |  207.288.6080 f

erin.mcdevitt@jax.org

 

 -----------------------------------

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309